Pioneering comprehensive AI solutions to improve the mammography screening process.

Our Mission

Whiterabbit is on a mission to make late-stage breast cancer a rarity by detecting it at its earliest stages using AI.

WRDensity

WRDensity is our AI-driven breast density software that assists radiologists in interpreting breast density to create uniformity of density assessment at the practice level.

  • 43% more consistent than radiologists when assessing patient exams across multiple years1
  • RIS/PACS compatible
  • Trained on over 600K images from the Mallinckrodt Institute of Radiology

WRRisk

WRRisk is our clinical decision support software for breast cancer risk assessment.

  • PACS integrated
  • Displays risk score and WRDensity data
  • Real-time feedback

Our Approach

In addition to existing products, we continue to advance our mission with several patents pending that stem from a proprietary data set across more than a million patients and partnerships with industry-leading institutions.

As we look ahead, we are focused on the AI-driven products to come that will continue to improve diagnostic accuracy, outcomes, and patient peace of mind.

Learn More About Us

Whiterabbit.ai by the numbers2.

2
M+

patients served through the Whiterabbit product suite

50
+

AI scientists, engineers, and healthcare professionals dedicated to our mission

11
M

Datapoints used to
train our AI

Find out how our products can help your business improve patient outcomes.

Footnotes

1. Statistics adapted from the American Cancer Society's publications, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020; the ACS website; the International Agency for Research on Cancer website; and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. (All sources accessed January 2022.)

2. Whiterabbit data on file.

1. Statistics adapted from the American Cancer Society's publications, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020; the ACS website; the International Agency for Research on Cancer website; and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. (All sources accessed January 2022.)

2. Whiterabbit data on file.

1. Statistics adapted from the American Cancer Society's publications, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020; the ACS website; the International Agency for Research on Cancer website; and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. (All sources accessed January 2022.)

2. Whiterabbit data on file.

1. Statistics adapted from the American Cancer Society's publications, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020; the ACS website; the International Agency for Research on Cancer website; and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. (All sources accessed January 2022.)

2. Whiterabbit data on file.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.